Home » Stocks » VIVO

Meridian Bioscience, Inc. (VIVO)

Stock Price: $22.50 USD 0.07 (0.31%)
Updated Apr 22, 2021 4:00 PM EDT - Market closed
After-hours: $22.54 +0.04 (0.18%) Apr 22, 5:06 PM
Market Cap 971.19M
Revenue (ttm) 299.16M
Net Income (ttm) 70.14M
Shares Out 43.10M
EPS (ttm) 1.61
PE Ratio 13.97
Forward PE 15.82
Dividend n/a
Dividend Yield n/a
Trading Day April 22
Last Price $22.50
Previous Close $22.43
Change ($) 0.07
Change (%) 0.31%
Day's Open 22.42
Day's Range 22.42 - 23.21
Day's Volume 372,491
52-Week Range 10.47 - 30.65

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

If you are screening the market for high-return investments, you may want to consider the three non-cyclical stocks listed below, as their earnings yields (as calculated via Joel Greenblatt (Trades, Por...

Other stocks mentioned: ENIA, FLGT
17 hours ago - GuruFocus

Meridian Bioscience (VIVO) closed at $22.43 in the latest trading session, marking a +1.72% move from the prior day.

1 day ago - Zacks Investment Research

CINCINNATI, April 19, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, will report second quarter fiscal 2021...

3 days ago - GlobeNewsWire

Meridian Bioscience (VIVO) closed the most recent trading day at $23.94, moving -1.4% from the previous trading session.

1 week ago - Zacks Investment Research

Meridian Bioscience Inc. (NASDAQ:VIVO) edged out GenMark Diagnostics Inc. (NASDAQ:GNMK) as the top gainer in the March GenomeWeb Index with a 25% boost in its share price compared to GenMark's 22.5% inc...

Other stocks mentioned: ADPT, BRN, GNMK, RHHBY
1 week ago - GuruFocus

Grab these four top stocks, HRC, OMI, MCK and VIVO, which continue to show promise amid the pandemic and can turn out to be wise investment choices for 2021.

Other stocks mentioned: BDX, HRC, MCK, OMI
3 weeks ago - Zacks Investment Research

CINCINNATI, April 01, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) a leading global provider of diagnostic testing solutions and life science raw materials, today announced that it ...

3 weeks ago - GlobeNewsWire

Is (VIVO) Outperforming Other Medical Stocks This Year?

3 weeks ago - Zacks Investment Research

These eight small-cap stocks are affordable, and they can deliver significant returns, especially during an economic recovery. The post 8 Small-Cap Stocks With Plenty of Cred appeared first on InvestorP...

Other stocks mentioned: AVNW, BGFV, CLFD, CTO, SGC, TCS
3 weeks ago - InvestorPlace

NEW YORK, March 24, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Meridian Bioscience, Inc. ("Meridian" or the "Company") (NASDAQ: VIVO). Such investors are advise...

4 weeks ago - PRNewsWire

Bull of the Day: Meridian Bioscience (VIVO)

1 month ago - Zacks Investment Research

New York, New York--(Newsfile Corp. - March 21, 2021) - Pomerantz LLP is investigating claims on behalf of investors of Meridian Bioscience, Inc. ("Meridian" or the "Company") (NASDAQ: VIVO). Such inves...

1 month ago - Newsfile Corp

NEW YORK, March 18, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Meridian Bioscience, Inc. ("Meridian" or the "Company") (NASDAQ: VIVO).  Such investors are advis...

1 month ago - PRNewsWire

Crocs (CROX), iRobot (IRBT), Sprouts Farmers Market (SFM), Meridian Bioscience (VIVO) & MEDIFAST (MED) are the top five companies boasting solid efficiency levels at present.

Other stocks mentioned: CROX, IRBT, MED, SFM
1 month ago - Zacks Investment Research

New York, New York--(Newsfile Corp. - March 14, 2021) - Pomerantz LLP is investigating claims on behalf of investors of Meridian Bioscience, Inc. ("Meridian" or the "Company") (NASDAQ: VIVO). Such inves...

1 month ago - Newsfile Corp

NEW YORK, March 12, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Meridian Bioscience, Inc. ("Meridian" or the "Company") (NASDAQ: VIVO). Such investors are advise...

1 month ago - PRNewsWire

As of late, it has definitely been a great time to be an investor in Meridian Bioscience, Inc. (VIVO).

1 month ago - Zacks Investment Research

CINCINNATI, March 08, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced today the lau...

1 month ago - GlobeNewsWire

New York, New York--(Newsfile Corp. - March 7, 2021) - Pomerantz LLP is investigating claims on behalf of investors of Meridian Bioscience, Inc. ("Meridian" or the "Company") (NASDAQ: VIVO). Such invest...

1 month ago - Newsfile Corp

CINCINNATI, March 04, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, announced today its participation in t...

1 month ago - GlobeNewsWire

NEW YORK, March 3, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Meridian Bioscience, Inc. ("Meridian" or the "Company") (NASDAQ: VIVO). Such investors are advised...

1 month ago - PRNewsWire

Meridian Bioscience (VIVO) is well positioned to outperform the market, as it exhibits above-average growth in financials.

1 month ago - Zacks Investment Research

Profitability analysis is considered one of the best possible ways to assess the prospects of a company.

Other stocks mentioned: CZNC, EBMT, FRBA, SBFG
1 month ago - Zacks Investment Research

Is (VIVO) Outperforming Other Medical Stocks This Year?

1 month ago - Zacks Investment Research

CINCINNATI, Feb. 23, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, updated its communication regarding the...

1 month ago - GlobeNewsWire

After submitting a written response to the FDA's request for additional information on Meridian Bioscience Inc's (NASDAQ: VIVO) Revogene SARS-CoV-2 test on February 16 and further discussions with the F...

1 month ago - Benzinga

CINCINNATI, Feb. 23, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, provided a further update on its applic...

1 month ago - GlobeNewsWire

New York, New York--(Newsfile Corp. - February 22, 2021) - Pomerantz LLP is investigating claims on behalf of investors of Meridian Bioscience, Inc. ("Meridian" or the "Company") (NASDAQ: VIVO). Such in...

2 months ago - Newsfile Corp

NEW YORK, Feb. 18, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Meridian Bioscience, Inc. ("Meridian" or the "Company") (NASDAQ: VIVO). Such investors are advised...

2 months ago - PRNewsWire

Cash indicates a company's true financial health. It offers the flexibility to make decisions, the means to make potential investments and the fuel to run its growth engine.

Other stocks mentioned: AVNW, CCS, MATX, PIPR
2 months ago - Zacks Investment Research

CINCINNATI, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, provided an update on its application f...

2 months ago - GlobeNewsWire

Let's take a look at these six top-ranked stocks with impressive net profit margins for a winning portfolio.

Other stocks mentioned: AVNW, CCS, MNSB, PIPR, PJT
2 months ago - Zacks Investment Research

Meridian Bioscience (VIVO) could produce exceptional returns because of its solid growth attributes.

2 months ago - Zacks Investment Research

Top Ranked Momentum Stocks to Buy for February 12th

Other stocks mentioned: CCS, PLT, USAK
2 months ago - Zacks Investment Research

Bull of the Day: Meridian Bioscience (VIVO)

2 months ago - Zacks Investment Research

New Strong Buy Stocks for February 10th

Other stocks mentioned: AMP, IMO, QRVO, SAFM
2 months ago - Zacks Investment Research

Low-beta stocks may be able to help sail through the choppy market conditions.

Other stocks mentioned: AVAV, SBSI, WSBF
2 months ago - Zacks Investment Research

Is (VIVO) Outperforming Other Medical Stocks This Year?

2 months ago - Zacks Investment Research

Infinity Pharmaceuticals (NASDAQ: INFI) shares are trading higher Friday after JPMorgan upgraded the stock from Underweight to Neutral. Infinity Pharmaceuticals is a clinical-stage biopharmaceutical com...

Other stocks mentioned: BCLI, INFI, ORTX
2 months ago - Benzinga

Meridian Bioscience (VIVO) delivered earnings and revenue surprises of 54.76% and 1.00%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

2 months ago - Zacks Investment Research

Shares of Meridian Bioscience (NASDAQ:VIVO) moved higher by 5.5% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share increased 550.00% year over year to $0....

2 months ago - Benzinga

CINCINNATI, Feb. 05, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced financial results for the first quarter ended December 31, 2020.

2 months ago - GlobeNewsWire

Meridian (VIVO) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

2 months ago - Zacks Investment Research

From vaccines to diagnostics, the opportunities in biotechnology are rich for those who do their homework.

Other stocks mentioned: AVXL, AXSM, HOLX, MRNA, NVAX, SAVA, VXRT
2 months ago - Zacks Investment Research

CINCINNATI, Feb. 03, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, today announced that it will increase p...

2 months ago - GlobeNewsWire

Meridian Bioscience's (VIVO) fiscal first-quarter results are likely to reflect strong performance by Life Science business line.

2 months ago - Zacks Investment Research

CINCINNATI, Feb. 02, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced today that it ...

2 months ago - GlobeNewsWire

In the latest trading session, Meridian Bioscience (VIVO) closed at $22.10, marking a +1.33% move from the previous day.

2 months ago - Zacks Investment Research

Strong signs of rebound in base sales volumes make us optimistic about VIVO, XRAY, and PDCO's results.

Other stocks mentioned: PDCO, XRAY
2 months ago - Zacks Investment Research

Meridian Bioscience (VIVO) closed at $22.60 in the latest trading session, marking a -0.88% move from the prior day.

3 months ago - Zacks Investment Research

About VIVO

Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, including real-time PCR amplification under the Revogene brand; isothermal DNA amplification under the Alethia brand; lateral flow immunoassay using fluorescent chemistry under the Curian brand; rapid im... [Read more...]

Industry
Diagnostics & Research
CEO
John Kenny
Employees
750
Stock Exchange
NASDAQ
Ticker Symbol
VIVO
Full Company Profile

Financial Performance

In 2020, VIVO's revenue was $253.67 million, an increase of 26.19% compared to the previous year's $201.01 million. Earnings were $46.19 million, an increase of 89.43%.

Financial Statements

Analyst Forecasts

According to 4 analysts, the average rating for VIVO stock is "Buy." The 12-month stock price forecast is 32.67, which is an increase of 45.20% from the latest price.

Price Target
$32.67
(45.20% upside)
Analyst Consensus: Buy